These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 37023988)

  • 21. Implications of bladder volume on target coverage and dose to critical structures during high dose rate intracavitary brachytherapy for cervical cancer: A dosimetric study.
    Patel RB; Gururajachar JM; Revathy T
    J Cancer Res Ther; 2019; 15(6):1207-1211. PubMed ID: 31898648
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Can MRI-only replace MRI-CT planning with a titanium tandem and ovoid applicator?
    Harkenrider MM; Patel R; Surucu M; Chinsky B; Mysz ML; Wood A; Ryan K; Shea SM; Small W; Roeske JC
    Brachytherapy; 2018; 17(5):747-752. PubMed ID: 29945764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A knowledge-based organ dose prediction tool for brachytherapy treatment planning of patients with cervical cancer.
    Yusufaly TI; Kallis K; Simon A; Mayadev J; Yashar CM; Einck JP; Mell LK; Brown D; Scanderbeg D; Hild SJ; Covele B; Moore KL; Meyers SM
    Brachytherapy; 2020; 19(5):624-634. PubMed ID: 32513446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of vaginal cylinder position on dose distribution in patients with endometrial carcinoma in treatment of vaginal cuff brachytherapy.
    Ozdemir Y; Dolek Y; Onal C
    J Contemp Brachytherapy; 2017 Jun; 9(3):230-235. PubMed ID: 28725246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dosimetric comparison of
    Shukla AK; Jangid PK; Rajpurohit VS; Verma A; Dangayach SK; Gagrani V; Rathore NK
    J Cancer Res Ther; 2019; 15(6):1212-1215. PubMed ID: 31898649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiobiological optimization comparison between pulse-dose-rate and high-dose-rate brachytherapy in patients with locally advanced cervical cancer.
    Annede P; Dumas I; Schernberg A; Tailleur A; Fumagalli I; Bockel S; Mignot F; Kissel M; Deutsch E; Haie-Meder C; Chargari C
    Brachytherapy; 2019; 18(3):370-377. PubMed ID: 30797698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of ICRU point doses and volumetric doses of organs at risk (OARs) in brachytherapy for cervical cancer.
    Vinod SK; Caldwell K; Lau A; Fowler AR
    J Med Imaging Radiat Oncol; 2011 Jun; 55(3):304-10. PubMed ID: 21696566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of bladder distension on dose distribution of vaginal vault brachytherapy in patients with endometrial cancer.
    Guler OC; Onal C; Acibuci I
    J Contemp Brachytherapy; 2015 Jan; 6(4):371-6. PubMed ID: 25834581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intra-cavitary brachytherapy in endometrial carcinoma: experience with cobalt-60 source.
    Rullán JAD; Miguelañez MTM; Fernández RC; Gallego MC; Sánchez MM; Vicente FG; García SS
    J Contemp Brachytherapy; 2022 Jun; 14(3):227-232. PubMed ID: 36199999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dosimetric analysis of 3D image-guided HDR brachytherapy planning for the treatment of cervical cancer: is point A-based dose prescription still valid in image-guided brachytherapy?
    Kim H; Beriwal S; Houser C; Huq MS
    Med Dosim; 2011; 36(2):166-70. PubMed ID: 20488690
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Boost modalities in cervical cancer: dosimetric comparison between intracavitary BT vs. intracavitary + interstitial BT vs. SBRT.
    Benkhaled S; Diakité K; Jullian N; Poeta S; Vandekerkhove C; Van Houtte P; Van Gestel D; De Caluwé A
    Radiat Oncol; 2023 Jun; 18(1):105. PubMed ID: 37381016
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dosimetric comparison of bladder, rectal, and vaginal surface doses between ovoids and cylinder-based vaginal brachytherapy in carcinoma of the endometrium.
    Kumar NP; Kumar A; Jayaprakash PG; Raghukumar P; James FV
    J Cancer Res Ther; 2018; 14(6):1191-1195. PubMed ID: 30488828
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gynecological brachytherapy for postoperative endometrial cancer: dosimetric analysis (Ir-192 vs Co-60).
    Tormo Ferrero V; Duque Ugarte R; Berenguer Francés MÁ; Cardenal Maciá R
    Clin Transl Oncol; 2017 Nov; 19(11):1409-1413. PubMed ID: 28516398
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Feasibility study of toxicity outcomes using GEC-ESTRO contouring guidelines on CT based instead of MRI-based planning in locally advanced cervical cancer patients.
    Koh V; Choo BA; Lee KM; Tan TH; Low JH; Ng SY; Ilancheran A; Shen L; Tang J
    Brachytherapy; 2017; 16(1):126-132. PubMed ID: 27816539
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Triple-tandem high-dose-rate brachytherapy for early-stage medically inoperable endometrial cancer: Initial report on acute toxicity and dosimetric comparison to stereotactic body radiation therapy.
    Kauffmann G; Wu T; Al-Hallaq H; Hasan Y
    Brachytherapy; 2017; 16(1):141-146. PubMed ID: 27866953
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Variable impact of intracavitary brachytherapy fractionation schedule on biologically effective dose to organs at risk in patients with cervical cancer.
    Christensen EN; Yu HZ; Klopp AH; Tsai JC; Lawyer AA; Court LE; Eifel PJ
    Brachytherapy; 2014; 13(3):240-9. PubMed ID: 24188993
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dose accumulation during vaginal cuff brachytherapy based on rigid/deformable registration vs. single plan addition.
    Sabater S; Andres I; Sevillano M; Berenguer R; Machin-Hamalainen S; Arenas M
    Brachytherapy; 2014; 13(4):343-51. PubMed ID: 24388615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A dosimetric comparison of Volumetric Modulated Arc Therapy (VMAT) and High Dose Rate (HDR) brachytherapy in localized cervical cancer radiotherapy.
    Wali L; Helal A; Darwesh R; Attar M
    J Xray Sci Technol; 2019; 27(3):473-483. PubMed ID: 30958322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of different fractionation schedules toward a single fraction in high-dose-rate brachytherapy as monotherapy for low-risk prostate cancer using 3-dimensional radiobiological models.
    Mavroidis P; Milickovic N; Cruz WF; Tselis N; Karabis A; Stathakis S; Papanikolaou N; Zamboglou N; Baltas D
    Int J Radiat Oncol Biol Phys; 2014 Jan; 88(1):216-23. PubMed ID: 24331667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dosimetric comparison of 3-dimensional planning techniques using an intravaginal multichannel balloon applicator for high-dose-rate gynecologic brachytherapy.
    Park SJ; Chung M; Demanes DJ; Banerjee R; Steinberg M; Kamrava M
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):840-6. PubMed ID: 24138921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.